Literature DB >> 30930056

Disruption of Telomerase RNA Maturation Kinetics Precipitates Disease.

Caitlin M Roake1, Lu Chen1, Ananya L Chakravarthy1, James E Ferrell2, Grazia D Raffa3, Steven E Artandi4.   

Abstract

Mutations in RNA-processing enzymes are increasingly linked to human disease. Telomerase RNA and related noncoding RNAs require 3' end-processing steps, including oligoadenylation. Germline mutations in poly(A)ribonuclease (PARN) cause accumulation of extended human telomerase RNA (hTR) species and precipitate dyskeratosis congenita and pulmonary fibrosis. Here, we develop nascent RNAend-seq to measure processing rates of RNA precursors. We find that mature hTR derives from extended precursors but that in PARN-mutant cells hTR maturation kinetically stalls and unprocessed precursors are degraded. Loss of poly(A)polymerase PAPD5 in PARN-mutant cells accelerates hTR maturation and restores hTR processing, indicating that oligoadenylation and deadenylation set rates of hTR maturation. The H/ACA domain mediates hTR maturation by precisely defining the 3' end, recruiting poly(A)polymerase activity, and conferring sensitivity to PARN regulation. These data reveal a feedforward circuit in which post-transcriptional oligoadenylation controls RNA maturation kinetics. Similar alterations in RNA processing rates may contribute to mechanisms of RNA-based human disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30930056      PMCID: PMC6525023          DOI: 10.1016/j.molcel.2019.02.033

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  35 in total

1.  RNA-based affinity purification reveals 7SK RNPs with distinct composition and regulation.

Authors:  J Robert Hogg; Kathleen Collins
Journal:  RNA       Date:  2007-04-24       Impact factor: 4.942

2.  A Polyadenylation-Dependent 3' End Maturation Pathway Is Required for the Synthesis of the Human Telomerase RNA.

Authors:  Duy Nguyen; Valérie Grenier St-Sauveur; Danny Bergeron; Fabien Dupuis-Sandoval; Michelle S Scott; François Bachand
Journal:  Cell Rep       Date:  2015-11-25       Impact factor: 9.423

Review 3.  Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs.

Authors:  A Gregory Matera; Rebecca M Terns; Michael P Terns
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

4.  A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis.

Authors:  Andrew S Venteicher; Eladio B Abreu; Zhaojing Meng; Kelly E McCann; Rebecca M Terns; Timothy D Veenstra; Michael P Terns; Steven E Artandi
Journal:  Science       Date:  2009-01-30       Impact factor: 47.728

5.  The RNA component of human telomerase.

Authors:  J Feng; W D Funk; S S Wang; S L Weinrich; A A Avilion; C P Chiu; R R Adams; E Chang; R C Allsopp; J Yu
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

6.  Recognition of adenosine residues by the active site of poly(A)-specific ribonuclease.

Authors:  Niklas Henriksson; Per Nilsson; Mousheng Wu; Haiwei Song; Anders Virtanen
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

Review 7.  Replication of telomeres and the regulation of telomerase.

Authors:  Verena Pfeiffer; Joachim Lingner
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

8.  Formation of the 3' end of U1 snRNA is directed by a conserved sequence located downstream of the coding region.

Authors:  N Hernandez
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

9.  Identification of truncated forms of U1 snRNA reveals a novel RNA degradation pathway during snRNP biogenesis.

Authors:  Hideaki Ishikawa; Yuko Nobe; Keiichi Izumikawa; Harunori Yoshikawa; Naoki Miyazawa; Goro Terukina; Natsuki Kurokawa; Masato Taoka; Yoshio Yamauchi; Hiroshi Nakayama; Toshiaki Isobe; Nobuhiro Takahashi
Journal:  Nucleic Acids Res       Date:  2013-12-05       Impact factor: 16.971

10.  Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.

Authors:  Siddharth Shukla; Jens C Schmidt; Katherine C Goldfarb; Thomas R Cech; Roy Parker
Journal:  Nat Struct Mol Biol       Date:  2016-03-07       Impact factor: 15.369

View more
  23 in total

1.  Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells.

Authors:  Neha Nagpal; Jianing Wang; Jing Zeng; Emily Lo; Diane H Moon; Kevin Luk; Roman O Braun; Lauri M Burroughs; Sioban B Keel; Christopher Reilly; R Coleman Lindsley; Scot A Wolfe; Albert K Tai; Patrick Cahan; Daniel E Bauer; Yick W Fong; Suneet Agarwal
Journal:  Cell Stem Cell       Date:  2020-04-21       Impact factor: 24.633

2.  Regulation of human telomerase RNA biogenesis and localization.

Authors:  Jian Qin; Chantal Autexier
Journal:  RNA Biol       Date:  2020-09-02       Impact factor: 4.652

3.  Regulation of poly(a)-specific ribonuclease activity by reversible lysine acetylation.

Authors:  Eden A Dejene; Yixuan Li; Zahra Showkatian; Hongbo Ling; Edward Seto
Journal:  J Biol Chem       Date:  2020-05-26       Impact factor: 5.157

Review 4.  Genetics of human telomere biology disorders.

Authors:  Patrick Revy; Caroline Kannengiesser; Alison A Bertuch
Journal:  Nat Rev Genet       Date:  2022-09-23       Impact factor: 59.581

5.  Small Molecules Restore Telomeres in Patient Stem Cells.

Authors:  Kirsten Ann Brenner; Jayakrishnan Nandakumar
Journal:  Trends Pharmacol Sci       Date:  2020-05-29       Impact factor: 14.819

6.  Chemical inhibition of PAPD5/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita.

Authors:  Siddharth Shukla; Ho-Chang Jeong; Christopher M Sturgeon; Roy Parker; Luis Francisco Zirnberger Batista
Journal:  Blood Adv       Date:  2020-06-23

7.  Analysis of RNA conformation in endogenously assembled RNPs by icSHAPE.

Authors:  Lu Chen; Howard Y Chang; Steven E Artandi
Journal:  STAR Protoc       Date:  2021-04-28

Review 8.  An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Authors:  Marena R Niewisch; Sharon A Savage
Journal:  Expert Rev Hematol       Date:  2019-09-10       Impact factor: 2.819

Review 9.  Regulation of human telomerase in homeostasis and disease.

Authors:  Caitlin M Roake; Steven E Artandi
Journal:  Nat Rev Mol Cell Biol       Date:  2020-04-02       Impact factor: 113.915

Review 10.  Telomerase RNA processing: Implications for human health and disease.

Authors:  Neha Nagpal; Suneet Agarwal
Journal:  Stem Cells       Date:  2020-09-01       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.